These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28117600)

  • 1. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
    Adamson-Small L; Potter M; Byrne BJ; Clément N
    Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells.
    Thomas DL; Wang L; Niamke J; Liu J; Kang W; Scotti MM; Ye GJ; Veres G; Knop DR
    Hum Gene Ther; 2009 Aug; 20(8):861-70. PubMed ID: 19419276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
    Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
    Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector.
    Ye GJ; Scotti MM; Thomas DL; Wang L; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):212-7. PubMed ID: 25357151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioreactor production of recombinant herpes simplex virus vectors.
    Knop DR; Harrell H
    Biotechnol Prog; 2007; 23(3):715-21. PubMed ID: 17461549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method.
    Chulay JD; Ye GJ; Thomas DL; Knop DR; Benson JM; Hutt JA; Wang G; Humphries M; Flotte TR
    Hum Gene Ther; 2011 Feb; 22(2):155-65. PubMed ID: 20812844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing.
    Selvaraj N; Wang CK; Bowser B; Broadt T; Shaban S; Burns J; Saptharishi N; Pechan P; Golebiowski D; Alimardanov A; Yang N; Mitra G; Vepachedu R
    Hum Gene Ther; 2021 Aug; 32(15-16):850-861. PubMed ID: 33397196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditions.
    Coplan L; Zhang Z; Ragone N; Reeves J; Rodriguez A; Shevade A; Bak H; Tustian AD
    Biotechnol Prog; 2024; 40(3):e3445. PubMed ID: 38450973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system.
    Feudner E; de Alwis M; Thrasher AJ; Ali RR; Fauser S
    J Virol Methods; 2001 Aug; 96(2):97-105. PubMed ID: 11445141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving adeno-associated vector yield in high density insect cell cultures.
    Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA
    J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system.
    Ye GJ; Scotti MM; Liu J; Wang L; Knop DR; Veres G
    Gene Ther; 2011 Feb; 18(2):135-44. PubMed ID: 20668485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of striatum and cortex tissues by adeno-associated viral vectors produced by herpes simplex virus- and baculovirus-based methods.
    Zhang HS; Kim E; Lee S; Ahn IS; Jang JH
    J Virol Methods; 2012 Jan; 179(1):276-80. PubMed ID: 22015677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Popularizing Recombinant Baculovirus-derived OneBac System for Laboratory Production of all Recombinant Adeno-associated Virus Vector Serotypes.
    Wu Y; Han Z; Duan M; Jiang L; Tian T; Jin D; Wang Q; Xu F
    Curr Gene Ther; 2021; 21(2):167-176. PubMed ID: 33461466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
    Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
    Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.